| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Domzalski David is a President And CEO at VYNE Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $272K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2020 | VYNE Vyne Therapeutics Inc. | President And CEO | Buy | 75,000 | $1.38 | $103,567.50 | +6.0% |